FATE THERAPEUTICS INC. - COMMON STOCK

NetDania - New 12 months Low: FATE THERAPEUTICS INC. - COMMON STOCK

15 Aug 2023 10:23:47 By NetDania Notify

NetDania - New 12 months Low: FATE THERAPEUTICS INC. - COMMON STOCK

14 Aug 2023 09:45:15 By NetDania Notify

NetDania - New 12 months Low: FATE THERAPEUTICS INC. - COMMON STOCK

11 Aug 2023 09:54:58 By NetDania Notify

NetDania - New 12 months Low: FATE THERAPEUTICS INC. - COMMON STOCK

10 Aug 2023 09:45:17 By NetDania Notify

NetDania - New 12 months Low: FATE THERAPEUTICS INC. - COMMON STOCK

09 Aug 2023 13:12:20 By NetDania Notify

Fate Therapeutics Reports Second Quarter 2023 Financial Results and Business Updates

08 Aug 2023 16:01:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: FATE THERAPEUTICS INC. - COMMON STOCK

08 Aug 2023 09:45:27 By NetDania Notify

NetDania - New 12 months Low: FATE THERAPEUTICS INC. - COMMON STOCK

07 Aug 2023 09:59:15 By NetDania Notify

NetDania - New 12 months Low: FATE THERAPEUTICS INC. - COMMON STOCK

03 Aug 2023 09:46:11 By NetDania Notify

NetDania - New 12 months Low: FATE THERAPEUTICS INC. - COMMON STOCK

02 Aug 2023 09:45:14 By NetDania Notify

NetDania - New 12 months Low: FATE THERAPEUTICS INC. - COMMON STOCK

01 Aug 2023 09:56:06 By NetDania Notify

Fate Therapeutics to Webcast Conference Call Reporting Second Quarter 2023 Financial Results

28 Jul 2023 08:00:00 By Nasdaq GlobeNewswire

Fate Therapeutics to Present at Upcoming June Investor Conferences

31 May 2023 08:00:01 By Nasdaq GlobeNewswire

Fate Therapeutics Reports First Quarter 2023 Financial Results and Business Updates

03 May 2023 16:01:00 By Nasdaq GlobeNewswire

Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2023 Financial Results

24 Apr 2023 08:00:00 By Nasdaq GlobeNewswire

Fate Therapeutics to Present at Upcoming March Investor Conferences

03 Mar 2023 16:01:00 By Nasdaq GlobeNewswire

Fate Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates

28 Feb 2023 16:01:00 By Nasdaq GlobeNewswire

Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2022 Financial Results

13 Feb 2023 08:00:00 By Nasdaq GlobeNewswire

Fate Therapeutics Announces Termination of Collaboration Agreement with Janssen, Pipeline Prioritization, Next-Generation Programs, and Key 2023 Initiatives

05 Jan 2023 17:00:00 By Nasdaq GlobeNewswire

Fate Therapeutics Features Multiple Novel Approaches to Eliminate Conditioning Chemotherapy for Off-the-shelf, iPSC-derived Cell Therapies at 2022 ASH Annual Meeting

13 Dec 2022 08:00:02 By Nasdaq GlobeNewswire